HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation Social Bookmarking                What's this?

Diagnosis and Classification of Diabetes Mellitus

Abbreviations: FPG, fasting plasma glucose • GAD, glutamic acid decarboxylase • GCT, glucose challenge test • GDM, gestational diabetes mellitus • HNF, hepatocyte nuclear factor • IFG, impaired fasting glucose • IGT, impaired glucose tolerance • MODY, maturity-onset diabetes of the young • WHO, World Health Organization

The first 300 words of the full text of this article appear below.

	DEFINITION AND DESCRIPTION OF DIABETES MELLITUS

 
Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. The chronic hyperglycemia of diabetes is associated with long-term damage, dysfunction, and failure of various organs, especially the eyes, kidneys, nerves, heart, and blood vessels.

Several pathogenic processes are involved in the development of diabetes. These range from autoimmune destruction of the β-cells of the pancreas with consequent insulin deficiency to abnormalities that result in resistance to insulin action. The basis of the abnormalities in carbohydrate, fat, and protein metabolism in diabetes is deficient action of insulin on target tissues. Deficient insulin action results from inadequate insulin secretion and/or diminished tissue responses to insulin at one or more points in the complex pathways of hormone action. Impairment of insulin secretion and defects in insulin action frequently coexist in the same patient, and it is often unclear which abnormality, if either alone, is the primary cause of the hyperglycemia.

Symptoms of marked hyperglycemia include polyuria, polydipsia, weight loss, sometimes with polyphagia, and blurred vision. Impairment of growth and susceptibility to certain infections may also accompany chronic hyperglycemia. Acute, life-threatening consequences of uncontrolled diabetes are hyperglycemia with ketoacidosis or the nonketotic hyperosmolar syndrome.

Long-term complications of diabetes include retinopathy with potential loss of vision; nephropathy leading to renal failure; peripheral neuropathy with risk of foot ulcers, amputations, and Charcot joints; and autonomic neuropathy causing gastrointestinal, genitourinary, and cardiovascular symptoms and sexual dysfunction. Patients with diabetes have an increased incidence of atherosclerotic cardiovascular, peripheral arterial, and cerebrovascular disease. Hypertension and abnormalities of lipoprotein metabolism are often found in people with diabetes.

The vast majority of cases of diabetes fall into two broad etiopathogenetic categories (discussed in greater detail below). In one category, type 1 diabetes, the cause is an absolute deficiency of . . . [Full Text of this Article]

	CLASSIFICATION OF DIABETES MELLITUS AND OTHER CATEGORIES OF GLUCOSE REGULATION

 
Type 1 diabetes (β-cell destruction, usually leading to absolute insulin deficiency)
Immune-mediated diabetes.
Idiopathic diabetes.
Type 2 diabetes (ranging from predominantly insulin resistance with relative insulin deficiency to predominantly an insulin secretory defect with insulin resistance)
Other specific types of diabetes
Genetic defects of the β-cell.
Genetic defects in insulin action.
Diseases of the exocrine pancreas.
Endocrinopathies.
Drug- or chemical-induced diabetes.
Infections.
Uncommon forms of immune-mediated diabetes.
Other genetic syndromes sometimes associated with diabetes.
Gestational diabetes mellitus (GDM)
Impaired glucose tolerance (IGT) and impaired fasting glucose (IFG)

	DIAGNOSTIC CRITERIA FOR DIABETES MELLITUS

 
Diagnosis of GDM
Testing for gestational diabetes.
One-step approach.
Two-step approach.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. Watada, H. Daida, and R. Kawamori Letter by Watada et al Regarding Article, "Two-Year Clinical Outcomes With Drug-Eluting Stents for Diabetic Patients With De Novo Coronary Lesion" Circulation, October 28, 2008; 118(18): e680 - e680. [Full Text] [PDF]

				T. J. Murtola, T. L. J. Tammela, J. Lahtela, and A. Auvinen Antidiabetic Medication and Prostate Cancer Risk: A Population-based Case-Control Study Am. J. Epidemiol., October 15, 2008; 168(8): 925 - 931. [Abstract] [Full Text] [PDF]

				A. R. Gosmanov and G. E. Umpierrez A Patient with Diabetes, Hepatitis C Virus Infection, and Hemochromatosis Gene Mutation Clin. Diabetes, October 1, 2008; 26(4): 174 - 176. [Full Text] [PDF]

				S. Kidambi and S. B. Patel Diabetes Mellitus: Considerations for Dentistry J Am Dent Assoc, October 1, 2008; 139(suppl_5): 8S - 18S. [Abstract] [Full Text] [PDF]

				R. M. E. Blumer, S. N. van der Crabben, M. E. Stegenga, M. W. Tanck, M. T. Ackermans, E. Endert, T. van der Poll, and H. P. Sauerwein Hyperglycemia prevents the suppressive effect of hyperinsulinemia on plasma adiponectin levels in healthy humans Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E613 - E617. [Abstract] [Full Text] [PDF]

				M. L. Kile and D. C. Christiani Environmental Arsenic Exposure and Diabetes JAMA, August 20, 2008; 300(7): 845 - 846. [Full Text] [PDF]

				K. M. Cowell Focus on Diagnosis: Type 2 Diabetes Mellitus Pediatr. Rev., August 1, 2008; 29(8): 289 - 292. [Full Text] [PDF]

				L. Soriano-Guillen, B. Hernandez-Garcia, J. Pita, N. Dominguez-Garrido, G. Del Rio-Camacho, and A. Rovira High-sensitivity C-reactive protein is a good marker of cardiovascular risk in obese children and adolescents. Eur. J. Endocrinol., July 1, 2008; 159(1): R1 - R4. [Abstract] [Full Text] [PDF]

				C. Triplitt and C. A. Alvarez Best Practices for Lowering the Risk of Cardiovascular Disease in Diabetes Diabetes Spectr, July 1, 2008; 21(3): 177 - 189. [Abstract] [Full Text] [PDF]

				C. Qiu, M. F. Cotch, S. Sigurdsson, M. Garcia, R. Klein, F. Jonasson, B. E.K. Klein, G. Eiriksdottir, T. B. Harris, M. A. van Buchem, et al. Retinal and Cerebral Microvascular Signs and Diabetes: The Age, Gene/Environment Susceptibility-Reykjavik Study Diabetes, June 1, 2008; 57(6): 1645 - 1650. [Abstract] [Full Text] [PDF]